AstraZeneca Pharma India Limited approved appointment of Ms. Bhavana Agrawal as a Director and also as a Whole Time Director of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,240 INR | +0.56% | +1.26% | +13.05% |
1st Jan change | Capi. | |
---|---|---|
+13.05% | 1.86B | |
+43.64% | 754B | |
+39.42% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.92% | 217B | |
-2.62% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director